TrialDrug design, development and therapy2017

Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.

Thomas J Dennison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.